InsidersTradesSigma
Follow the Thiogenesis Therapeutics, Corp. (formerly Rozdil Capital Corporation) stock price and the full directors' dealings record of the company, a listed issuer based in Canada. Shares are listed on the CA market, under the supervision of SEDI. Market capitalisation: €28.5m. The latest transaction was filed on 19 August 2026 (00 - Opening Balance-Initial SEDI Report). Among the most active insiders: Aharon, Gilad. The full history is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
3 of 3 declarations
Thiogenesis Therapeutics, Corp. es una empresa de biotecnología centrada en el desarrollo de tratamientos innovadores para enfermedades graves. Anteriormente conocida como Rozdil Capital Corporation, cotiza en la XTSE.